FTSE 100 news / Companies and sectors / AstraZeneca / 18 October 2026

AstraZeneca (AZN): news on Sunday 18 October 2026

+5.7 positive

Coverage was mainly about AstraZeneca opening a new corporate office in Mumbai and announcing a new collaboration with insitro. A Times feature on its turn towards America and a Summit Therapeutics deal mention added a neutral to mildly positive tone.

What drove it

Mumbai office opening
insitro collaboration
US strategy

The 6 stories

Each headline's own score, strongest first. Links go to the publisher.

+7.5 AstraZeneca announces new insitro collaboration - ad-hoc-news.de ad-hoc-news.de
New collaboration with insitro supports its R&D pipeline.
+6.7 AstraZeneca Strengthens India Presence with New Mumbai Corporate Office Medical Dialogues
Strengthened India presence through new corporate office.
+6.7 AstraZeneca India opens new Mumbai office for next phase of growth through innovation BioSpectrum India
New Mumbai office signals investment in India growth.
+6.3 AstraZeneca opens new Mumbai corporate office Indian Pharma Post
New Mumbai corporate office shows expansion in India.
+4.2 Summit Therapeutics (SMMT) Stock Fair Value Edges Higher After AstraZeneca Deal And Trial Focus Yahoo Finance
Summit stock story references AstraZeneca deal; modestly positive, AZN secondary.
+0.8 AstraZeneca is a British behemoth. Why is it turning to America? The Times
Feature on AstraZeneca's strategic shift towards America; broadly neutral.

AstraZeneca: every day · Pharma and healthcare on 18 October 2026 · FTSE 100 overview for the day